About the Authors

Kirsi Auro, Mervi Alanne, Kati Kristiansson, Kaisa Silander, Leena Peltonen, Markus Perola
Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland

Kari Kuulasmaa, Veikko Salomaa
Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland

Leena Peltonen, Markus Perola
Department of Medical Genetics, University of Helsinki, Helsinki, Finland

Leena Peltonen
The Broad Institute of MIT and Harvard, Boston, Massachusetts, United States of America

Corresponding Author

kirsi.auro@ktl.fi

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

K. Auro was responsible for the SNP selection and the data analyses, and participated in the genotyping. M. Alanne was responsible for the sample management and participated in the genotyping and the data analyses. K. Kristiansson participated in the genotyping and the data analyses. K. Silander participated in the genotyping and the whole-genome amplification of the DNA. K. Kuulasmaa participated in the study design and the assessment of the quality of the phenotypic data and the data analyses. V. Salomaa participated in the study design, recruitment of the FINRISK participants, and assessment of the clinical diagnoses. L. Peltonen participated in the study design and the data analyses. M. Perola is the principal investigator and holds responsibility of the overall study design and the data analyses. All authors participated in writing the manuscript.